Professor of Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
William G. Wierda, MD, PhD, is Professor of Medicine, Deputy Chair and Center Medical Director for the Department of Leukemia, and Executive Medical Director inpatient medical services at The University of Texas MD Anderson Cancer Center.
Dr. Wierda received his Doctor of Philosophy in microbiology and immunology and his medical degree from the University of Health Sciences/The Chicago Medical School. He subsequently completed an internship and residency in internal medicine at Duke University Medical Center, followed by a fellowship in hematology and medical oncology at the University of California, San Diego.
Dr. Wierda has been faculty at UT MDACC since 2001. Dr. Wierda's research focuses on studying immunology and immune function in patients with chronic lymphocytic and developing combined targeted therapies and immune-based therapeutic strategies for patients with hematologic malignancies, particularly CLL. He has served as principal investigator or co-investigator for numerous clinical trials, lectured nationally and internationally, and published extensively on clinical and translational aspects of CLL and drug and treatment development.
Dr. Wierda is an executive member of the International Workshop on CLL and member of the American College of Physicians, the American Society of Hematology, the American Society of Clinical Oncology, the American Association of Immunologists, and the European Society of Hematology.
Dr. Wierda serves as Chair of the NCCN CLL/SLL and Hairy Cell Leukemia Panel, the Value Pathways Task Force Member for the NCCN CLL/SLL/Hairy Cell Leukemia Panel. He also serves as peer reviewer for several journals and is an editorial board member for JNCCN—Journal of the National Comprehensive Cancer Network and a scientific review committee member for the NCCN Oncology Research Program.
Session 5: Management of Treatment Lines Throughout the Course of CLL
Sunday, September 14, 2025
08:15 - 09:25 CEST
